Abstract:Abstract Protein A (SpA) alone or immobilized on bacteria (e.g., Cowan strain I), collodion charcoal, or on Sepharose have been used in serotherapy of cancer in humans and experimental animals. Because SpA forms complexes with IgG that can activate complement, and the physiologic response during treatment often involves hypocomplementemia and reactions that are similar to those induced by anaphylatoxins, we used sensitive and specific radioimmunoassays to test the ability of SpA reagents to generate C3a, C4a, and C5a from human serum. The yield of anaphylatoxins depended on the dose of SpA, with the maximum generation of C3a (47 to 55 micrograms/ml) and C5a (1.4 to 1.9 micrograms/ml) being produced with levels of SpA that were maximally precipitated from serum. Maximum C4a levels (up to 15 micrograms/ml) were obtained at concentrations of SpA equal to or greater than the dose required to give optimal precipitation. The maximum concentrations of anaphylatoxins correspond to essentially quantitative conversions of C3 to C3a, C4 to C4a, and 40% of C5 to C5a after correction for levels found in serum incubated in pyrogen-free saline. Preformed insoluble complexes prepared from either serum or monomeric IgG also were capable of generating anaphylatoxins in fresh whole serum up to levels approximately equal to those observed in serum treated directly with an optimal amount of SpA. The preformed complexes from serum or IgG generated similar high concentrations of anaphylatoxins when carried through four sequential incubations with fresh serum, and complexes that contained approximately 1 microgram SpA were still active. Preincubating the insoluble complexes with chicken anti-SpA serum did not alter their activity. Incubation of serum with collodion charcoal coated with SpA, in a system that models the perfusion technique used to treat cancer, produced complexes that generated significant levels of C3a compared with levels found in serum passaged over albumin charcoal or in untreated serum. The C3a levels in serum from the albumin collodion charcoal were not significantly different from those found in untreated serum. Similar amounts of C3a, C4a, or C5a were observed in serum incubated with differing numbers of bacteria representing a strain of S. aureus rich in cell bound SpA (Cowan strain I) or a strain (Wood 46) deficient in SpA. This suggests that in intact bacteria, cell wall factors other than SpA (e.g., peptidoglycan) are predominantly responsible for generating anaphylatoxins.(ABSTRACT TRUNCATED AT 400 WORDS)

Chemistry and biology of the anaphylatoxin related serum peptide system. I. Purification, crystallization and properties of classical anaphylatoxin from rat serum

Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release

Purification, sequencing and synthesis of natriuretic and vasoactive rat atrial peptide

Life‐threatening antibodies: The discovery of anaphylaxis

Molecular design for antagonisting C5a anaphyl atoxin and the activity examination of the peptide

Chemical Synthesis and Racemic Crystallization of Rat C5a-desArg

Purification of clinical-grade disulfide stabilized antibody fragment variable— Pseudomonas exotoxin conjugate (dsFv-PE38) expressed in Escherichia coli

Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.

Isolation and Purification of Anaphylactic Antibody from Guinea Pig and Preliminary Research on Its Role in Passive Cutaneous Anaphylaxis Test (PCA)

Purification, characterization and conformational analysis of a haemorrhagin from the venom of Agkistrodon acutus.

Study of Molecular Design for Antagonisting C5a Anaphylatoxin

Formation of histamine-releasing activity from albumin by medium conditioned by endotoxin-stimulated rat peritoneal macrophages

A Novel Designed Single Domain Antibody on 3-D Structure of Ricin A Chain Remarkably Blocked Ricin-Induced Cytotoxicity

Purification and Characterization of a Novel Anticoagulation Factor (ACF II) from the Venom of Agkistrodon Acutus

The Mast Cell, Contact, and Coagulation System Connection in Anaphylaxis

Benzylamine oxidase and histaminase: purification and crystallization of an enzyme from pig plasma

Purification and Characterization of a Novel Antiplatelet Peptide from Deinagkistrodon acutus Venom

A secretory system for extracellular production of spider neurotoxin huwentoxin-I in Escherichia coli

Purification, Crystallization And Preliminary X-Ray Diffraction Analysis Of An Acidic Phospholipase A(2) With Vasoconstrictor Activity From Agkistrodon Halys Pallas Venom

Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins

Neutralization and Binding Activity of a Human Single-Chain Antibody to Ricin Toxin